![](../../files/images/goods/1315380-70-1.png)
VU591 hydrochloride
CAS No. 1315380-70-1
VU591 hydrochloride ( —— )
产品货号. M22454 CAS No. 1315380-70-1
VU591 HydroHClide 是一种选择性肾外髓质钾通道 (Kir1.1, ROMK) 拮抗剂 (IC50:0.24 μM)。被认为可以阻断 Kir1.1 通道的细胞内孔。在浓度高达 10 μM 时对 Kir7.1 没有影响;不抑制 Kir2.1、Kir2.3 或 Kir4.1。
纯度: >98% (HPLC)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥3013 | 有现货 |
![]() ![]() |
10MG | ¥4447 | 有现货 |
![]() ![]() |
25MG | ¥7039 | 有现货 |
![]() ![]() |
50MG | ¥9477 | 有现货 |
![]() ![]() |
100MG | ¥12798 | 有现货 |
![]() ![]() |
500MG | ¥25677 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称VU591 hydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述VU591 HydroHClide 是一种选择性肾外髓质钾通道 (Kir1.1, ROMK) 拮抗剂 (IC50:0.24 μM)。被认为可以阻断 Kir1.1 通道的细胞内孔。在浓度高达 10 μM 时对 Kir7.1 没有影响;不抑制 Kir2.1、Kir2.3 或 Kir4.1。
-
产品描述VU591 hydrochloride is a selective renal outer medullary potassium channel (Kir1.1, ROMK) antagonist (IC50:0.24 μM).?Thought to block the intracellular pore of the Kir1.1 channel.?Exhibits no effect on Kir7.1 at concentrations up to 10 μM;?does not inhibit Kir2.1, Kir2.3 or Kir4.1.?Displays similar potency to VU 590?.
-
体外实验VU591 hydrochloride is a selective ROMK inhibitor and a ROMK channel pore blocker. VU591 can bind serum protein and has high metabolic stability.
-
体内实验VU591 hydrochloride (i.c.v.; 1.842 μg) significantly decreases the immobile time in TST. Animal Model:Male ICR miceDosage:1.842 μg Administration:i.c.v.; 1.842 μg Result:Showed antidepressive effect in the tail suspension test (TST).
-
同义词——
-
通路Cell Cycle/DNA Damage
-
靶点Potassium Channel
-
受体Kir1.1
-
研究领域——
-
适应症——
化学信息
-
CAS Number1315380-70-1
-
分子量404.76
-
分子式C16H13ClN6O5
-
纯度>98% (HPLC)
-
溶解度DMSO:16 mg/mL (39.53 mM; Need ultrasonic)
-
SMILESCl.[O-][N+](=O)c1ccc2nc(COCc3nc4ccc(cc4[nH]3)[N+]([O-])=O)[nH]c2c1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Bhave G, et al. Development of a selective small-molecule inhibitor of Kir1.1, the renal outer medullary potassium channel. Mol Pharmacol. 2011 Jan;79(1):42-50.